India Pesticides Q1 FY27 Revenue Declines 9.2% to ₹256 Crore Amidst Subdued Demand
India Pesticides Limited reported Q1 FY27 revenue of ₹256 crore, down 9.2% YoY. EBITDA was ₹39 crore, and PAT was ₹23 crore. The company received EU TEQ approval for a fungicide, expecting an additional ₹30-40 crore annual revenue. New product development and capacity expansion are underway, with Hamirpur facility targeting ₹1,000 crore revenue in 4 years.
While the revenue decline is a concern, the EU approval for a fungicide and ongoing capacity expansions suggest potential for future growth, moderating the immediate impact.
The company reported a year-on-year decline in revenue and profit due to subdued demand and increased costs, indicating a negative short-term outlook.
India Pesticides Limited (IPL) reported its Q1 FY27 financial results, with consolidated revenue from operations at ₹256 crore, a 9.2% year-on-year decline compared to ₹282 crore in Q1 FY26. The company's performance was impacted by subdued domestic demand for key herbicides like Pretilachlor, deficient rainfall leading to slower sowing, and increased employee and fuel costs.
EBITDA for the quarter stood at ₹39 crore, with an EBITDA margin of 15.4%, down from ₹52 crore and 18.4% in Q1 FY26. Profit After Tax (PAT) was ₹23 crore, compared to ₹35 crore in the previous year, resulting in a PAT margin of 8.9%. The decline in operating margins was also attributed to a one-time write-off of export receivables amounting to ₹2.5 crore and higher job work charges.
Export revenue contributed approximately 35% of the total revenue, amounting to ₹89 crore, stable compared to ₹87 crore in Q1 FY26. Domestic revenue was ₹167 crore, down from ₹195 crore in the corresponding quarter last year.
A significant development during the quarter was the receipt of Technical Equivalence (TEQ) approval from the European Union for a fungicide product, which is expected to open up new market opportunities and potentially add ₹30-40 crore in annual revenue. The company is also developing a new fungicide product, currently imported from China, at its Sandila facility, aiming to become a major producer in India.
IPL is progressing with its manufacturing expansion plans, including the development of its Hamirpur facility, where two out of ten blocks are operational. The company anticipates that the Hamirpur facility, once fully developed with 8-10 blocks over the next 3-4 years, could generate revenues of up to ₹1,000 crore. Capex for FY27 is planned at approximately ₹70-100 crore for the Hamirpur facility and ₹25-30 crore for the Sandila facility, with a total annual capex of around ₹100 crore for both facilities.
The company is focused on improving operational efficiencies, strengthening its product portfolio by adding new molecules, and expanding its global presence to reduce dependence on single products. Looking ahead, IPL expects Q3 and Q4 to be better, guiding for a lower single-digit growth for the full fiscal year FY27.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.